{"id":39407,"date":"2024-03-18T01:00:00","date_gmt":"2024-03-18T01:00:00","guid":{"rendered":"https:\/\/eodishasamachar.com\/en\/2024\/03\/18\/zuellig-pharma-and-karo-healthcare-strengthen-partnership-across-key-markets-in-asia\/"},"modified":"2024-03-18T01:00:00","modified_gmt":"2024-03-18T01:00:00","slug":"zuellig-pharma-and-karo-healthcare-strengthen-partnership-across-key-markets-in-asia","status":"publish","type":"post","link":"https:\/\/eodishasamachar.com\/en\/2024\/03\/18\/zuellig-pharma-and-karo-healthcare-strengthen-partnership-across-key-markets-in-asia\/","title":{"rendered":"Zuellig Pharma and Karo Healthcare strengthen partnership across key markets in Asia"},"content":{"rendered":"<p> \n<\/p>\n<div lang=\"en\">\n<p>        SINGAPORE &#8211;<br \/>\n<a href=\"https:\/\/www.media-outreach.com\" rel=\"sponsored\">Media OutReach Newswire<\/a> &#8211; 18 March 2024 &#8211; Zuellig Pharma, a leading healthcare solutions company in Asia, has announced that it has expanded its commercialisation partnership with Karo Healthcare (&#8220;Karo&#8221;). Founded in 1987, Karo is a leading European consumer healthcare company headquartered in Stockholm, Sweden, with products available in more than 90 countries.<\/p>\n<p>Under the new agreement, Zuellig Pharma will be the exclusive commercialisation partner for Karo&#8217;s over-the-counter (OTC) brand Lamisil\u00ae, a product for the treatment of fungal infections, across Hong Kong, Malaysia, Philippines, Singapore, South Korea, Taiwan and Vietnam. With industry-leading coverage across healthcare professionals and retail pharmacies in Asia and in-market commercial expertise, ZP Therapeutics, the commercial division of Zuellig Pharma, will be steering this partnership.\n<\/p>\n<p>Zuellig Pharma has had a strong commercialisation partnership with Karo since 2019 for its product portfolio in the Philippines, Vietnam, Singapore and Indonesia.\n<\/p>\n<p>&#8220;We are excited to work with Karo to expand access and availability of its products. As an integrated healthcare solutions company, this partnership will also play a key role in the strengthening of Zuellig Pharma&#8217;s consumer health portfolio as we grow in key markets such as Korea and Taiwan,&#8221; said John Graham, Group CEO, Zuellig Pharma. &#8220;I&#8217;m confident that ZP Therapeutics&#8217; extensive partner network and proven commercial expertise will be critical in facilitating greater access for in-demand consumer healthcare products in Asia.&#8221;\n<\/p>\n<p><a href=\"https:\/\/www.zuelligpharma.com\/\" class=\"social-media-link\"><img loading=\"lazy\" style=\"margin-right: 7px;vertical-align: middle;display: inline-block !important;width: 24px\" width=\"24\" height=\"24\" data-no-lazy=\"1\" data-src=\"https:\/\/release.media-outreach.com\/Release\/templates\/images\/socialMedia\/generic_link.png\" class=\"lazyload\" src=\"data:image\/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==\"\/><noscript><img loading=\"lazy\" style=\"margin-right: 7px;vertical-align: middle;display: inline-block !important;width: 24px\" width=\"24\" height=\"24\" data-no-lazy=\"1\" data-src=\"https:\/\/release.media-outreach.com\/Release\/templates\/images\/socialMedia\/generic_link.png\" class=\"lazyload\" src=\"data:image\/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==\"\/><noscript><img loading=\"lazy\" style=\"margin-right: 7px;vertical-align: middle;display: inline-block !important;width: 24px\" src=\"https:\/\/release.media-outreach.com\/Release\/templates\/images\/socialMedia\/generic_link.png\" width=\"24\" height=\"24\" data-no-lazy=\"1\"\/><\/noscript><\/noscript>https:\/\/www.zuelligpharma.com\/<\/a><br \/><a href=\"https:\/\/sg.linkedin.com\/company\/zuellig-pharma\" class=\"social-media-link\"><img loading=\"lazy\" style=\"margin-right: 7px;vertical-align: middle;display: inline-block !important;width: 24px\" width=\"24\" height=\"24\" data-no-lazy=\"1\" data-src=\"https:\/\/release.media-outreach.com\/Release\/templates\/images\/socialMedia\/iconmonstr-linkedin-1-24.png\" class=\"lazyload\" src=\"data:image\/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==\"\/><noscript><img loading=\"lazy\" style=\"margin-right: 7px;vertical-align: middle;display: inline-block !important;width: 24px\" src=\"https:\/\/release.media-outreach.com\/Release\/templates\/images\/socialMedia\/iconmonstr-linkedin-1-24.png\" width=\"24\" height=\"24\" data-no-lazy=\"1\"\/><\/noscript>https:\/\/sg.linkedin.com\/company\/zuellig-pharma<\/a>            <\/p>\n<p><b>Hashtag: <\/b>#ZuelligPharma #ZPTherapeutics #KaroHealthcare #Healthcare #Drugs #Medicines #ConsumerHealthcare<\/p>\n<p>\n            <em>The issuer is solely responsible for the content of this announcement.<\/em>\n        <\/p>\n<p>        <img loading=\"lazy\" src=\"http:\/\/track.media-outreach.com\/index.php\/WebView\/283712\/4121\" alt=\"\" width=\"1\" height=\"1\" style=\"width:1px;height:1px;\"\/>\n    <\/div>\n\n<br \/><a href=\"https:\/\/www.media-outreach.com\/news\/singapore\/2024\/03\/18\/283712\/\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>SINGAPORE &#8211; Media OutReach Newswire &#8211; 18 March 2024 &#8211; Zuellig Pharma, a leading healthcare solutions company in Asia, has announced that it has expanded its commercialisation partnership with Karo Healthcare (&#8220;Karo&#8221;). Founded in 1987, Karo is a leading European consumer healthcare company headquartered in Stockholm, Sweden, with products available in more than 90 countries. &hellip;<\/p>\n","protected":false},"author":1,"featured_media":39408,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[60],"tags":[],"_links":{"self":[{"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/posts\/39407"}],"collection":[{"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/comments?post=39407"}],"version-history":[{"count":0,"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/posts\/39407\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/media\/39408"}],"wp:attachment":[{"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/media?parent=39407"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/categories?post=39407"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/tags?post=39407"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}